NCT02558582

Brief Summary

Pulmonary Hypertension (PH) is a serious disease with a dismal prognosis when left untreated. Advances in medical therapy have improved survival according to recent registries and systematic reviews, but are associated with high healthcare costs. Earlier studies in Heidelberg, Germany showed good evidence for the effect of exercise training on improving exercise performance, quality of life and pulmonary hemodynamics in patients with pulmonary hypertension. The main objectives of the present project are:

  1. 1.to investigate the quality of the implementation of a standardized 3 week in-hospital exercise training program on markers of outcome and disease severity in PH-patients in Switzerland immediately after training and after 3 and 12 month.
  2. 2.to look whether training with hyperoxia vs. standard care might be more effective.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

September 14, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 24, 2015

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 2, 2022

Status Verified

November 1, 2022

Enrollment Period

8.3 years

First QC Date

September 14, 2015

Last Update Submit

November 1, 2022

Conditions

Keywords

Pulmonary arterial hypertensionChronic thromboembolic pulmonary hypertensionRehabilitationOxygen

Outcome Measures

Primary Outcomes (2)

  • 6 Minute walking test

    Change from Baseline to 15 weeks

  • Constant cardiopulmonary exercise testing change in endurance time

    Change from Baseline to 15 weeks

Secondary Outcomes (8)

  • Quality of Life (questionnaire)

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

  • Sit-to-Stand (physiological parameter)

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

  • Stair Ascent (physiological parameter)

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

  • Cognitive function (questionnaire)

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

  • Hemodynamic (physiological parameter)

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

  • +3 more secondary outcomes

Other Outcomes (1)

  • Hospitalisation days

    Baseline, 3 weeks, 15 weeks, 6 and 12 months

Study Arms (4)

Immediate Rehabilitation

EXPERIMENTAL

The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.

Behavioral: respiratory and exercise therapy

Immediate Rehabilitation with oxygen

EXPERIMENTAL

The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.

Behavioral: respiratory and exercise therapy with supplemental oxygen

Delayed Rehabilitation

EXPERIMENTAL

Waiting group that participates in the rehabilitation program after 3 months. The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.

Behavioral: respiratory and exercise therapy

Delayed Rehabilitation with oxygen

EXPERIMENTAL

Waiting group that participates in the rehabilitation program after 3 months. The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.

Behavioral: respiratory and exercise therapy with supplemental oxygen

Interventions

The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training.

Delayed RehabilitationImmediate Rehabilitation

The PH specific rehabilitation consists of: bicycle ergometer training, respiratory training, dumbbell-training and (mental) gait training. Patients who are not already under long-term oxygen therapy (LTOT) due to daytime hypoxemia will additionally be randomized to receive standardized supplemental oxygen therapy (SSOT) during training and nights.

Delayed Rehabilitation with oxygenImmediate Rehabilitation with oxygen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • WHO functional class II-IV
  • PH diagnosed by right heart catheter showing:
  • Baseline mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg
  • Baseline pulmonary vascular resistance (PVR) \> 240 dyn x s x cm-5
  • Baseline pulmonary capillary wedge pressure (PCWP) ≤ 15 mm Hg
  • Patients receiving maximal PH therapy including intensified treatment with diuretics and who have been stable for 2 months before entering the study
  • PH target therapy should not be expected to change during the entire 15-week study period
  • Negative pregnancy test (β-HCG) at the start of the trial
  • Able to understand and willing to sign the Informed Consent Form

You may not qualify if:

  • PH due to significant left heart disease (Wedge ≥ 15mmHg) or lung disease (FEV1 ≤ 60% predicted)
  • Pregnancy at study onset
  • Walking disability
  • Any change in disease-targeted therapy within the last 2 months
  • Any subject who is scheduled to receive another investigational drug during the course of this study
  • Any other relevant concomitant disease
  • Systolic blood pressure \< 85 mmHg
  • History or suspicion of inability to cooperate adequately

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UniversityHospital Zurich, Department of Pulmonology

Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Hypertension, PulmonaryPulmonary Arterial Hypertension

Interventions

Respiratory RateExercise Therapy

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Silvia Ulrich Somaini, PD Dr.

    UniversityHospital Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Silvia Ulrich Somaini, PD Dr.

CONTACT

Stéphanie Saxer, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2015

First Posted

September 24, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

November 2, 2022

Record last verified: 2022-11

Locations